Cargando…

Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis

Detalles Bibliográficos
Autores principales: Di, Mengyang, Cui, Can, Kothari, Shalin K., Zeidan, Amer M., Podoltsev, Nikolai A., Neparidze, Natalia, Shallis, Rory M., Wang, Rong, Ma, Xiaomei, Huntington, Scott F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198937/
https://www.ncbi.nlm.nih.gov/pubmed/35240689
http://dx.doi.org/10.1182/bloodadvances.2021006934
_version_ 1784727753500655616
author Di, Mengyang
Cui, Can
Kothari, Shalin K.
Zeidan, Amer M.
Podoltsev, Nikolai A.
Neparidze, Natalia
Shallis, Rory M.
Wang, Rong
Ma, Xiaomei
Huntington, Scott F.
author_facet Di, Mengyang
Cui, Can
Kothari, Shalin K.
Zeidan, Amer M.
Podoltsev, Nikolai A.
Neparidze, Natalia
Shallis, Rory M.
Wang, Rong
Ma, Xiaomei
Huntington, Scott F.
author_sort Di, Mengyang
collection PubMed
description
format Online
Article
Text
id pubmed-9198937
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-91989372022-06-15 Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis Di, Mengyang Cui, Can Kothari, Shalin K. Zeidan, Amer M. Podoltsev, Nikolai A. Neparidze, Natalia Shallis, Rory M. Wang, Rong Ma, Xiaomei Huntington, Scott F. Blood Adv Research Letter American Society of Hematology 2022-06-03 /pmc/articles/PMC9198937/ /pubmed/35240689 http://dx.doi.org/10.1182/bloodadvances.2021006934 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
spellingShingle Research Letter
Di, Mengyang
Cui, Can
Kothari, Shalin K.
Zeidan, Amer M.
Podoltsev, Nikolai A.
Neparidze, Natalia
Shallis, Rory M.
Wang, Rong
Ma, Xiaomei
Huntington, Scott F.
Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis
title Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis
title_full Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis
title_fullStr Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis
title_full_unstemmed Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis
title_short Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis
title_sort survival of mantle cell lymphoma in the era of bruton tyrosine kinase inhibitors: a population-based analysis
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198937/
https://www.ncbi.nlm.nih.gov/pubmed/35240689
http://dx.doi.org/10.1182/bloodadvances.2021006934
work_keys_str_mv AT dimengyang survivalofmantlecelllymphomaintheeraofbrutontyrosinekinaseinhibitorsapopulationbasedanalysis
AT cuican survivalofmantlecelllymphomaintheeraofbrutontyrosinekinaseinhibitorsapopulationbasedanalysis
AT kotharishalink survivalofmantlecelllymphomaintheeraofbrutontyrosinekinaseinhibitorsapopulationbasedanalysis
AT zeidanamerm survivalofmantlecelllymphomaintheeraofbrutontyrosinekinaseinhibitorsapopulationbasedanalysis
AT podoltsevnikolaia survivalofmantlecelllymphomaintheeraofbrutontyrosinekinaseinhibitorsapopulationbasedanalysis
AT neparidzenatalia survivalofmantlecelllymphomaintheeraofbrutontyrosinekinaseinhibitorsapopulationbasedanalysis
AT shallisrorym survivalofmantlecelllymphomaintheeraofbrutontyrosinekinaseinhibitorsapopulationbasedanalysis
AT wangrong survivalofmantlecelllymphomaintheeraofbrutontyrosinekinaseinhibitorsapopulationbasedanalysis
AT maxiaomei survivalofmantlecelllymphomaintheeraofbrutontyrosinekinaseinhibitorsapopulationbasedanalysis
AT huntingtonscottf survivalofmantlecelllymphomaintheeraofbrutontyrosinekinaseinhibitorsapopulationbasedanalysis